middle.news
Cambium Bio Raises A$1 Million at Premium from Strategic Shareholder
8:44am on Wednesday 22nd of July, 2026 AEST
•
Healthcare
Read Story
Cambium Bio Raises A$1 Million at Premium from Strategic Shareholder
8:44am on Wednesday 22nd of July, 2026 AEST
Key Points
A$1.008 million raised via placement at A$0.48 per share
Placement price 17.1% above prior closing share price
Strategic shareholder increases stake from 12.25% to 18.5%
Funds earmarked for pivotal Phase 3 trial of Elate Ocular®
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cambium Bio (ASX:CMB)
OPEN ARTICLE